CDC Urges All International Travelers to Receive Measles Vaccinations

The CDC now recommends that all Americans, regardless of destination, get the measles-mumps-rubella (MMR) vaccine before traveling abroad to prevent infection and transmission.
In a recent update to their health guidelines, U.S. health authorities are now strongly recommending that all Americans traveling abroad get a measles vaccination, regardless of the destination country. Previously, the Centers for Disease Control and Prevention (CDC) emphasized the importance of vaccination mainly for travel to regions experiencing active measles outbreaks. However, the latest guidance expands this recommendation to include travel to any foreign country, reflecting the global risk of measles exposure.
The CDC's revised advice recommends two doses of the measles-mumps-rubella (MMR) vaccine for all individuals aged 1 year and older. Infants between 6 and 11 months who are traveling should receive an early dose to ensure protection during their journey. This update is driven by recent events such as the Colorado measles outbreak linked to an international flight, highlighting that the risk of contracting measles extends beyond outbreak zones to the transit environment itself.
Measles continues to pose a significant health threat in the United States, with over 1,000 cases reported so far this year. Experts, including researchers like Ashley Darcy-Mahoney from George Washington University, see this development as a crucial step in preventing further transmission. The CDC explicitly points out that measles can be contracted not only from exposure in abroad countries but also on airplanes and during travel activities.
This approach signifies a shift from targeting only localized outbreaks to adopting a broader, more preventative public health strategy. The updated guidance underscores the importance of vaccination for all travelers to stay protected and to help curb the spread of measles within the U.S. and worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
GLP-1 Medications Show Promise in Reducing Chronic Migraine Days by Half
New research indicates that GLP-1 medications, used for diabetes and obesity, may halve the number of monthly migraine days, offering hope for improved treatment options.
Advances in Whole Genome Sequencing Enhance Breast Cancer Treatment and Clinical Trial Matching
New research shows that whole genome sequencing can uncover genetic markers to personalize breast cancer treatment and improve clinical trial matching, potentially benefiting thousands of patients annually.
Gene Expression as a Predictor of Treatment Response in Thyroid Cancer
Gene expression profiling shows promise in predicting thyroid cancer response to radioactive iodine, enabling more personalized treatments and improved patient outcomes.
Innovative Kidney Transplant Matching Method Promises Improved Long-Term Success
A new method utilizing SIRP-alpha matching alongside traditional HLA testing may enhance long-term kidney transplant success by better predicting rejection risks.



